ストックスクリーナーアプリを入手
0.2097
0.48%
0.0007
前日終値:
$0.209
開ける：
$0.21
24時間の取引高:
300.01K
Relative Volume:
0.17
時価総額：
$9.84M
収益：
-
当期純損益:
$-40.10M
株価収益率:
-0.0222
EPS:
-9.46
ネットキャッシュフロー:
$-36.99M
1週間 パフォーマンス:
-10.90%
1か月 パフォーマンス:
-28.45%
6か月 パフォーマンス:
-32.26%
1年 パフォーマンス:
-86.27%
1日の値動き範囲:
$0.2039
$0.2144
1週間の範囲:
$0.2039
$0.24
52週間の値動き範囲:
$0.1281
$1.68
Mustang Bio Inc Stock (MBIO) Company Profile
MBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| MBIO | 0.2096 | 9.84M | 0 | -40.10M | -36.99M | -9.46 |
| VRTX | 449.90 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 745.15 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 595.64 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.18 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.06 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-05-18 | 開始されました | BTIG Research | Buy |
| 2020-10-02 | 開始されました | B. Riley FBR | Buy |
| 2019-11-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-08-13 | 開始されました | H.C. Wainwright | Buy |
| 2019-06-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-12-21 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Mustang Bio Inc (MBIO) 最新ニュース
Mustang Bio's Interim CFO Resigns After 10 Months - MarketWatch
Mustang Bio Faces Nasdaq Delisting and Leadership Changes - TipRanks
Mustang Bio, Inc. Announces CFO Changes - Marketscreener.com
ARMISTICE CAPITAL, LLC Acquires New Stake in Mustang Bio Inc - GuruFocus.com
Fortress Biotech Inc. (FBIOP) Quarterly 10-Q Report - Quartzy
Mustang Bio gets extension for Nasdaq compliance By Investing.com - Investing.com South Africa
Crude Oil Brent (F) (QAX25) Quote - The Globe and Mail
Mustang Bio gets extension for Nasdaq compliance - Investing.com
Mustang Bio Receives Positive Listing Determination from Nasdaq - The Manila Times
Mustang Bio Secures Critical Nasdaq Extension, Faces January 2025 Deadline for $1 Compliance | MBIO Stock News - StockTitan
Virus Therapy Gets Orphan Drug Designation for Glioma Treatment - www.oncnursingnews.com/
Mustang Bio Inc (MBIO) Quarterly 10-Q Report - Quartzy
Mustang Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment - Yahoo Finance
Toll Brothers Inc (TOL-N) QuotePress Release - The Globe and Mail
Mustang Bio gains FDA Orphan Drug Status for glioma treatment - Investing.com India
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for - GlobeNewswire
Mustang Bio gains FDA Orphan Drug Status for glioma treatment By Investing.com - Investing.com UK
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma - Yahoo Finance
Mustang Bio sets annual meeting date, deadlines for proposals - Investing.com
Everquote Inc Cl A (EVER-Q) QuotePress Release - The Globe and Mail
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Data Readouts At EHA Congress 2021 (APTO, XFOR, GBT, CRIS…) - RTTNews
Mustang Bio Secures $4M through Strategic Warrant Agreement - Yahoo Finance
Revance Therapeutics Inc’s (RVNC) Stock Is Harder To Predict Than You Think - Stocks Register
Mustang Bio, Inc. Appoints David Jin as A Member of the Board - Marketscreener.com
Mustang Bio secures $4 million from warrant exercises - Investing.com India
Mustang Bio secures $4 million from warrant exercises By Investing.com - Investing.com South Africa
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds - GlobeNewswire
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket - Benzinga
Chimeric Antigen Receptor T (CAR-T) Cells Market Research Analysis 2024-2033 | Growth, Size, Analysis, Insi... - WhaTech
Investor’s Toolkit: Key Ratios for Assessing Mustang Bio Inc (MBIO)’s Performance - The Dwinnex
A stock that deserves closer examination: Mustang Bio Inc (MBIO) - US Post News
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket - MSN
Mustang Bio Inc (MBIO) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
There is no doubt that Mustang Bio Inc (MBIO) ticks all the boxes. - SETE News
Marshall Wace LLP Has $92.82 Million Position in StoneCo Ltd. (NASDAQ:STNE) - MarketBeat
Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug - Yahoo Finance
Market Update: Mustang Bio Inc (MBIO) Sees Negative Movement, Closing at 0.21 - The Dwinnex
Mustang Bio (MBIO) Stock Price, News & Analysis - MarketBeat
Wild mustangs available for adoption in Cullman County - WVTM13 Birmingham
MBIO’s Stock Tango: The Dance of Gains and Losses in 2023 - The InvestChronicle
Daily Market Movement: Mustang Bio Inc (MBIO) Sees a -12.17 Decrease, Closing at 0.22 - The Dwinnex
Review: The striking, confident 2025 Ford Mustang, reimagined for the modern era - MarketWatch
DEADLINE ALERT for OM, SAGE, and SMCI: The Law Offices of - GlobeNewswire
Drugmaker for rare disease soars 1,200% in last year - Kursiv Media
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Worcester biopharma faces delisting from Nasdaq - Worcester Business Journal
Bokf Na Purchases 2,755 Shares of USANA Health Sciences, Inc. (NYSE:USNA) - Defense World
As Interest in EVs Ebbs, Ford Reveals its Fastest, Most Powerful Mustang Ever- the 2025 Mustang GTD - Torque News
Ford To Roll Out Limited Edition Street Legal Race Car Variant Of Mustang As Early As This Year - MSN
Mustang Bio Inc (MBIO) 財務データ
収益
当期純利益
現金流量
EPS
1.80%
0.42%
大文字化:
|
ボリューム (24 時間):